Keep up to date with every new upload!

Join free & follow wiltonpark
Share
HIV/AIDS: accessibility of innovation

HIV/AIDS: accessibility of innovation

Biomedical advances have brought improved treatment for HIV/AIDs, but how accessible is innovation beyond the rich, developed world? And have healthcare systems been able to exploit this new availability of advanced drugs?

This is the second podcast recorded during our meeting on Financing continued scale-up in HIV treatment: more money for years gained and more years gained for the money.

Contributors are:

Ernest Darkoh, Founding Partner, BroadReach Healthcare, Johannesburg

Shannon Kowalski, Senior Program Officer, The Open Society Foundations, New York

John Martin. Chairman, Board of Directors and Chief Executive Officer, Gilead Sciences Inc, Foster City CA.

More details: http://ow.ly/7BqyO

Comments